[ad_1]
Genmab A/S (OTCMKTS:GNMSF – Get Loose File)’s inventory worth handed above its 50 day transferring moderate all through buying and selling on Friday . The inventory has a 50 day transferring moderate of $310.68 and traded as prime as $320.50. Genmab A/S stocks ultimate traded at $314.75, with a quantity of one,158 stocks.
Genmab A/S Inventory Down 2.0 %
The industry’s 50 day transferring moderate is $310.68 and its 200 day transferring moderate is $347.77.
Genmab A/S (OTCMKTS:GNMSF – Get Loose File) ultimate issued its quarterly income effects on Tuesday, November seventh. The corporate reported $4.72 income in line with proportion (EPS) for the quarter. The industry had earnings of $692.80 million for the quarter. Genmab A/S had a go back on fairness of 15.03% and a internet margin of 25.54%.
Genmab A/S Corporate Profile
Genmab A/S develops antibody therapeutics for the remedy of most cancers and different illnesses basically in Denmark. The corporate markets DARZALEX, a human monoclonal antibody for the remedy of sufferers with a couple of myeloma (MM); teprotumumab for the remedy of thyroid eye illness; ofatumurnab, a human monoclonal antibody to regard power lymphocytic leukemia (CLL) and a couple of sclerosis; and Amivantamab for complex or metastatic gastric or esophageal most cancers and NSCLC.
Featured Articles
Obtain Information & Rankings for Genmab A/S Day by day – Input your electronic mail deal with beneath to obtain a concise day by day abstract of the newest information and analysts’ scores for Genmab A/S and similar corporations with MarketBeat.com’s FREE day by day electronic mail publication.
[ad_2]
